BIRLAMCHI OCHIQ BURCHAKLI GLAUKOMASI BOR BEMORLARNI KOMPLEKS DAVOLASHDA CYTOFLAVIN SAMARADORLIGINI O’RGANISH

Tuychibaeva D.M., Sultanova H.R., Kayumova S.A.

Передовая Офтальмология · 2024-yil

Annotatsiya

Relevance. The term “glaucoma” unites a large group of eye diseases of various origins with a progradient, chronic course. Purpose of the study. Study of the neuroprotective effect of the drug Cytoflavin in patients with POAG with normalized IOP based on clinical and functional indicators of the organ of vision. Material and methods. 60 patients were examined with a diagnosis of primary open-angle glaucoma (POAG) stages I, II and III. All patients were divided into 2 groups depending on the treatment received. Results. Cytoflavin has a pronounced neuroprotective effect in POAG, effectively protecting nervous tissue and slowing down apoptosis. In addition to improving the clinical and functional indicators of the organ of vision, we noted an improvement in general well-being, attention and overall performance in all patients. Conclusion. Analysis of the results obtained indicates a fairly high clinical effectiveness of the drug Cytoflavin in the conservative treatment of patients with POAG with compensated IOP and can be recommended as background neuroprotective therapy.

Maqola ma’lumotlari
MualliflarTuychibaeva D.M., Sultanova H.R., Kayumova S.A.
JurnalПередовая Офтальмология
Nashr sanasi2024-04-21
Jild6
Son6
Betlar34-39
Tiluz
DOI10.57231/j.ao.2023.6.6.007

Передовая Офтальмология jurnalidan boshqa maqolalar

Передовая Офтальмология — barcha maqolalar